|Systematic (IUPAC) name|
|CAS Registry Number|
|Molecular mass||202.30 g/mol|
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a psychedelic drug. It was first made in 1958 by E. H. Young.  In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency  which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
Legal Status 1
United States 1.1
- Alabama 1.1.1
- Florida 1.1.2
- United States 1.1
- See also 2
- References 3
5,N,N-TMT is not scheduled at the federal level in the United States, but it could be considered an analog of 5-MeO-DMT, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.
- Young EH, J. Chem. Soc. 3493 (1958)
- Glennon et al., J. Med. Chem. 22:428-432 (1979)
- Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158
- §1308.11 Schedule I.
- Alabama Senate Bill SB 333: Controlled Substances
- Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL